AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PYC THERAPEUTICS LTD

2.230

-0.020-0.89%

Volume:1.78M

Turnover:4.04M

Market Cap:2.19B

PE:-26.87

High:2.320

Open:2.300

Low:2.210

Close:2.250

52wk High:2.320

52wk Low:0.847

Shares:983.26M

Float Shares:348.08M

Volume Ratio:1.46

T/O Rate:0.51%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.083

EPS(LYR):-0.101

ROE:-10.14%

ROA:-6.13%

PB:3.16

PE(LYR):-22.19

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

PYC Therapeutics (ASX:PYC) Shares Chase Revenue Growth Despite Deep Losses

Simply Wall St.

ASX Biggest Losers

MT Newswires Live

ASX Biggest Gainers

MT Newswires Live

PYC Therapeutics Secures Approval for Higher Dosage in Phase 1b Multiple Ascending Dose Study in Polycystic Kidney Disease

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/PYC.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PYC.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PYC.AU\",,,,,undefined,":{"symbol":"PYC.AU","market":"AU","secType":"STK","nameCN":"PYC THERAPEUTICS LTD","latestPrice":2.23,"timestamp":1788149471306,"preClose":2.25,"halted":0,"volume":1778562,"delay":0,"changeRate":-0.008888888888888898,"nameEN":"PYC THERAPEUTICS LTD","floatShares":348081085,"shares":983260447,"eps":-0.083,"marketStatus":"Trading","change":-0.02,"latestTime":"08-31 14:11:45 AEST","open":2.3,"high":2.32,"low":2.21,"amount":4038108,"amplitude":0.048889,"askPrice":2.23,"askSize":6946,"bidPrice":2.22,"bidSize":13409,"shortable":3,"etf":0,"ttmEps":-0.083,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788156000000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":2.25,"openAndCloseTimeList":[[1788134400000,1788156000000]],"volumeRatio":1.463251,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"PYC.AU","preClose":2.25,"auctionPrice":2.3,"auctionVolume":19094,"auctionTime":1788134344611,"referenceTime":1787913003093,"auction":1,"marketStatus":"盘前竞价","timestamp":1788134344611}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PYC.AU\",,,,,undefined,":{"symbol":"PYC.AU","floatShares":348081085,"roa":"-6.13%","roe":"-10.14%","lyrEps":-0.100508,"volumeRatio":1.463251,"shares":983260447,"dividePrice":0,"high":2.32,"amplitude":0.048889,"preClose":2.25,"low":2.21,"week52Low":0.847,"pbRate":"3.16","psRate":"55.26","week52High":2.32,"institutionHeld":0,"latestPrice":2.23,"committee":0.317514,"eps":-0.083,"divideRate":0,"volume":1778562,"delay":0,"ttmEps":-0.083,"open":2.3,"prevYearClose":1.655,"prevWeekClose":2.25,"prevMonthClose":1.7,"prevQuarterClose":1.685,"fiveDayClose":2.1,"twentyDayClose":1.82,"sixtyDayClose":1.235,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PYC.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-11-15","symbol":"PYC.AU","defaultRemindTime":1731625200000,"type":"split","dateTimestamp":1731589200000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"AU","date":"2024-03-18","symbol":"PYC.AU","defaultRemindTime":1710716400000,"type":"split","dateTimestamp":1710680400000,"forFactor":988235,"toFactor":1000000,"ratio":0.988235}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PYC.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PYC.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663010707","title":"PYC Therapeutics (ASX:PYC) Shares Chase Revenue Growth Despite Deep Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2663010707","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663010707?lang=en_us&edition=fundamental","pubTime":"2026-08-30 04:19","pubTimestamp":1788034748,"startTime":"0","endTime":"0","summary":"PYC Therapeutics stock closed at A$2.25 on Friday after a strong run over the past month, yet the fresh numbers still tell a story of a biotech deep in investment mode rather than profit harvest. The headline is the loss from continuing operations of A$43.8 million over the trailing twelve months, set against revenue of A$39.7 million. For long term holders, the bigger question now is how to weigh that loss profile against a P/B of 3.2x, which sits below both direct peers and the broader...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-pyc/pyc-therapeutics-shares/news/pyc-therapeutics-asxpyc-shares-chase-revenue-growth-despite","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-pyc/pyc-therapeutics-shares/news/pyc-therapeutics-asxpyc-shares-chase-revenue-growth-despite","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PYC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657418693","title":"ASX Biggest Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2657418693","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657418693?lang=en_us&edition=fundamental","pubTime":"2026-08-07 11:25","pubTimestamp":1786073116,"startTime":"0","endTime":"0","summary":"Here are the ASX-listed companies with the biggest losses on Friday.4DMedical : -8%, AU$4.25ResMed : -6%, AU$29.55EchoIQ : -6%, AU$1.46Phylogica : -5%, AU$2.02DroneShield : -5%, AU$2.16EQ Resources : -5%, AU$0.31Block: -4%, AU$113.35Zip : -4%, AU$2.84Brazilian Rare Earths : -4%, AU$4.30Macmahon Holdings : -3%, AU$1.00","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7158","MAH.AU","XYZ.AU","EIQ.AU","BK7115","BK7007","EQR.AU","PYC.AU","DRO.AU","BK7016","BK7093","BK7094","ZIP.AU","4DX.AU","BK7095","RMD.AU","BRE.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656899965","title":"ASX Biggest Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2656899965","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656899965?lang=en_us&edition=fundamental","pubTime":"2026-08-04 10:59","pubTimestamp":1785812397,"startTime":"0","endTime":"0","summary":"Here are the ASX-listed companies with the biggest gains on Tuesday.DroneShield (ASX:DRO): +12%, AU$2.03MAAS Group Holdings (ASX:MGH): +11%, AU$5.52Almonty Industries CDI 1:1 (ASX:AII): +10%, AU$17.71","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PYC.AU","BK7055","360.AU","AII.AU","BK7067","BK7115","BK7016","BK7043","BK7010","BK7503","BK7095","BK7165","MP1.AU","BNZ.AU","MGH.AU","EOS.AU","EQR.AU","CQE.AU","DRO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655585889","title":"PYC Therapeutics Secures Approval for Higher Dosage in Phase 1b Multiple Ascending Dose Study in Polycystic Kidney Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2655585889","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655585889?lang=en_us&edition=fundamental","pubTime":"2026-07-29 11:20","pubTimestamp":1785295208,"startTime":"0","endTime":"0","summary":"PYC Therapeutics  said it received Safety Review Committee approval in July to escalate dosing in the phase 1b part C multiple ascending dose study in polycystic kidney disease patients to the higher dose group of 2.4 milligrams per kilogram of its drug candidate PYC-003, according to a Wednesday Australian bourse filing.The company said it also received approval for an open-label extension of the ongoing study to enable continuous dosing of the drug candidate for a period of up to 24 months.It had AU$669 million of cash on hand as of June 30, per the filing.PYC Therapeutics' shares rose nearly 2% in recent trading on Wednesday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","PYC.AU","BK4139","BK4539","BK4007","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":7,"pageCount":1,"totalSize":28,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PYC.AU\",params:#limit:6,delay:true,,,undefined,":[]}}